Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$123,181
+$3,120 QoQ
Shares Held
786
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,354
of 1,602 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crews Bank & Trust holds $15,101,212 across 12 Drug Manufacturers - General names. NVS ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,653 | $6,780,378 | |
| 2 | JNJ |
Johnson & Johnson
|
12,235 | $3,107,322 | |
| 3 | ABBV |
AbbVie Inc.
|
8,457 | $2,128,119 | |
| 4 | AMGN |
Amgen Inc
|
3,433 | $1,243,157 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,824 | $876,884 | |
| 6 | PFE |
Pfizer Inc
|
18,187 | $437,942 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,221 | $243,214 | |
| 8 | NVS |
Novartis AG
This page
|
786 | $123,181 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,181 | 786 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $120,061 | 786 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $108,365 | 786 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $100,796 | 786 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $90,152 | 745 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $83,052 | 745 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $72,495 | 745 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||